ACHV - Achieve Life Sciences under pressure on proposing stock offering
Achieve Life Sciences (ACHV) trading 7.9% down after hours on launching a proposed underwritten public offering for offering and selling shares; underwriters granted 30-day option to purchase up to an additional 15% of the shares.Offer size, terms not yet disclosed.Net proceeds to be used for funding ongoing cytisinicline development, other clinical research and development and for general corporate purposes.
For further details see:
Achieve Life Sciences under pressure on proposing stock offering